We've found
						31,654
						 archived clinical trials in
						Cardiology
					
				We've found
						31,654
						 archived clinical trials in
						Cardiology
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
	
	Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
	
Updated: 2/8/2017
  
  
  	  An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
		Status: Enrolling	
	Updated: 2/8/2017
Click here to add this to my saved trials
		    
			
	Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
	
Updated: 2/9/2017
  
  
  Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus, Question 3
		Status: Enrolling	
	Updated: 2/9/2017
	
	Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
	
Updated: 2/9/2017
  
  
  	  Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus, Question 3
		Status: Enrolling	
	Updated: 2/9/2017
Click here to add this to my saved trials
		    
			
	Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
	
Updated: 2/9/2017
  
  
  Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
		Status: Enrolling	
	Updated: 2/9/2017
	
	Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
	
Updated: 2/9/2017
  
  
  	  Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
		Status: Enrolling	
	Updated: 2/9/2017
Click here to add this to my saved trials
		    
			
	Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
	
Updated: 2/9/2017
  
  
  Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
		Status: Enrolling	
	Updated: 2/9/2017
	
	Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
	
Updated: 2/9/2017
  
  
  	  Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
		Status: Enrolling	
	Updated: 2/9/2017
Click here to add this to my saved trials
		    
			
	Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
	
Updated: 2/9/2017
  
  
  Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
		Status: Enrolling	
	Updated: 2/9/2017
	
	Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
	
Updated: 2/9/2017
  
  
  	  Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
		Status: Enrolling	
	Updated: 2/9/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
	
	Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
	
Updated: 2/14/2017
  
  
  	  Functional Impact of GLP-1 for Heart Failure Treatment
		Status: Enrolling	
	Updated: 2/14/2017
Click here to add this to my saved trials
		    
			
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
	
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  	  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
Click here to add this to my saved trials
		    
			
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
	
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  	  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
Click here to add this to my saved trials
		    
			
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
	
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  	  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
Click here to add this to my saved trials
		    
			
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
	
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  	  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
Click here to add this to my saved trials
		    
			
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
	
	Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
	
Updated: 2/16/2017
  
  
  	  A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
		Status: Enrolling	
	Updated: 2/16/2017
Click here to add this to my saved trials